As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...

There are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...

When mid-caps were rising, every concern on valuation was treated as unnecessary caution. Investors who advised patience were told they wer...

For the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...

Has a peace deal been agreed on by the US and Iran? Will the fragile ceasefire hold? No one can answer these questions with any certainty. ...

Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...

If you are putting fresh money into the market, it might be a good idea to stay with companies that don't have much to do with global suppl...

Assam's Chief Minister Himanta Biswa Sarma initiated three major projects in Sarusajai. These include a Medanta Super-Speciality Hospital, ...

Global Health, known for its Medanta hospitals, is set to invest approximately Rs 500 crore in establishing a 400-bed super speciality hosp...

For the year ended on March 31, 2024, the company said its net profit increased to Rs 478 crore as against Rs 326 crore in FY23.

The rally has been more pronounced since the company announced its December quarter earnings on Thursday where reported a consolidated PAT ...

Medanta is a leading tertiary care service provider, with established presence in north and east India. It has built its hospitals network ...

The total issue size of the IPO is ₹2,205 crore, which includes a fresh issue of ₹500 crore and an offer for sale (OFS) of up to ₹1,705 cro...

Global Health, backed by private equity investors such as Carlyle Group and Temasek, operates a network of five hospitals under the 'Medant...

Manipal is looking to acquire Medanta for Rs 5,500-6,000 crore in negotiations that have been running for over nine months.

KKR swooped down with a late bid after Manipal’s negotiations ran into valuation differences.

Medanta’s founder, renowned heart surgeon Naresh Trehan, is likely to retain a sliver of his stake although the final details are yet to be...